세계의 아테렉토미 기기 시장 규모 : 유형별, 용도별, 최종사용자별, 지역 범위별 및 예측

Atherectomy Devices Market Size And Forecast

Atherectomy Devices Market size was valued at USD 1.63 Billion in 2024 and is projected to reach USD 2.54 Billion by 2031, growing at a CAGR of 6.25% from 2024 to 2031.

Atherectomy devices are specialized medical instruments designed to remove plaque from the walls of arteries, improving blood flow in patients suffering from atherosclerosis. These devices work by cutting, grinding, or vaporizing arterial plaque that narrows or blocks the arteries, particularly in peripheral or coronary artery disease. Atherectomy procedures are often minimally invasive and are used in combination with other interventions such as angioplasty or stenting. They are highly valuable for treating calcified or hard plaque that is difficult to manage with conventional balloon angioplasty alone.

The global market for atherectomy devices is expected to grow significantly due to rising cardiovascular disease prevalence, an aging population, and advancements in device technology. New developments in imaging and navigation technologies, along with the demand for less invasive procedures, are expected to drive innovation in this field.

The increasing adoption of atherectomy procedures in emerging markets, improved healthcare infrastructure, and favorable reimbursement policies are likely to expand the scope and accessibility of these devices. Enhanced precision, better safety profiles, and integration with AI-powered diagnostics are also promising directions for the future of atherectomy devices.

Global Atherectomy Devices Market Dynamics

The key market dynamics that are shaping the global atherectomy devices market include:

Key Market Drivers:

Rising Prevalence of Peripheral Artery Disease (PAD): The increasing incidence of PAD is a major driver for the atherectomy devices market. According to the Centers for Disease Control and Prevention (CDC), approximately 6.5 million people aged 40 and older in the United States have PAD. The prevalence of PAD increases with age, affecting 12-20% of individuals over 60 years old. This growing patient population necessitates effective treatment options like atherectomy devices.

Increasing Adoption of Minimally Invasive Procedures: There's a growing preference for minimally invasive treatments, which is boosting the demand for atherectomy devices. The Society for Vascular Surgery reports that endovascular procedures, including atherectomy, have increased by 30% over the past decade. This trend is driven by shorter hospital stays, reduced complications, and faster recovery times associated with minimally invasive techniques.

Technological Advancements in Atherectomy Devices: Ongoing innovations in atherectomy technology are expanding the market. According to a report by the American Heart Association, the use of drug-coated balloon angioplasty in conjunction with atherectomy has shown a 50% reduction in restenosis rates compared to traditional methods. This improved efficacy is driving the adoption of advanced atherectomy devices in both hospitals and outpatient settings.

Key Challenges:

High Cost of Devices and Procedures: Atherectomy devices and the associated procedures are expensive, limiting their accessibility in low-income regions and for uninsured patients. High equipment costs, along with the need for highly skilled operators, increase the financial burden on healthcare providers. In some regions, inadequate reimbursement policies further add to the challenges, making it difficult for hospitals to adopt these devices widely. The lack of cost-effectiveness, especially when compared to alternative treatment methods like angioplasty or stenting, hampers their broader acceptance in cost-sensitive markets.

Complexity of Procedures: Atherectomy procedures require a high level of skill and experience from healthcare professionals, particularly due to the delicate nature of plaque removal in complex or calcified arterial blockages. Any error during the procedure can lead to complications, such as arterial perforation or plaque embolization, posing a significant risk to the patient. This complexity deters many healthcare facilities, especially in developing regions, from adopting the procedure.

Limited Reimbursement Policies: In many countries, the reimbursement framework for atherectomy procedures is not as comprehensive as it is for more traditional treatments like angioplasty. This lack of coverage creates financial strain on both healthcare providers and patients. Where reimbursement does exist, it may not cover the entire cost of the procedure, creating hesitancy in hospitals to invest in the necessary equipment. Varying reimbursement policies across different regions adds complexity for global manufacturers looking to market atherectomy devices in multiple countries.

Key Trends:

Growing Demand for Real-Time Analytics: With businesses increasingly relying on real-time data for decision-making, in-memory databases are becoming essential. These databases offer ultra-fast data retrieval and processing by storing data directly in RAM, eliminating the need for slower disk-based storage. Industries like finance, e-commerce, and telecom require real-time analytics to make split-second decisions, enhancing operational efficiency. As the need for instantaneous data processing grows, the demand for in-memory databases is expected to rise, especially in high-frequency trading, fraud detection, and personalized customer experiences.

Adoption of In-Memory Computing for Big Data: The proliferation of big data has led to the widespread adoption of in-memory computing (IMC). Traditional disk-based databases struggle to process and analyze massive datasets in real-time, while in-memory databases offer high-speed access and analysis, even with large volumes of data. IMDBs significantly reduce latency in big data analytics, providing faster insights for better decision-making. This is particularly important in industries like healthcare, retail, and IoT, where vast amounts of data need to be processed quickly to gain actionable insights.

Rising Use of Cloud-Based In-Memory Databases: Cloud adoption is accelerating the growth of the in-memory database market as businesses move their data infrastructure to cloud environments. Cloud-based in-memory databases offer scalability, flexibility, and cost-efficiency compared to on-premises solutions. They also provide faster provisioning and the ability to scale resources on demand, which is crucial for businesses with fluctuating workloads. The shift to cloud computing is driving organizations to adopt in-memory databases to take advantage of high-speed data processing in a more flexible and cost-effective manner.

Global Atherectomy Devices Market Overview

The increased occurrence of orthopedic illnesses such as bone tumors and osteomyelitis is driving market expansion. The most prevalent application of atherectomy devices is to treat persistent osteomyelitis. The increase in sports injuries and other types of trauma, bone fractures, and bone lesions is projected to fuel market expansion in the future. The increasing prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD) is likely to drive the Atherectomy Devices market. Atherectomy devices play a significant role in the diagnosis and treatment of peripheral artery disease (PAD).

When compared to traditional therapies, the devices provide various advantages, including a lower risk of problems and a higher degree of comfort during surgery. The rapidly increasing usage of Laser Atherectomy Devices is expected to fuel market growth. When compared to mechanical systems, these systems provide various advantages, including more versatility, increased efficiency, and the removal of the requirement for embolic protective devices.

Furthermore, laser-embedded atherectomy devices can remove thrombi, dissolve procoagulant reactants, and debulk the underlying plaque without causing damage to the surrounding tissue. As a result, the increased use of laser atherectomy devices is projected to boost the market in the coming years. The growing emphasis on technology developments is expected to boost the market in the coming years.

In addition, substantial research supporting the fast expansion of medical infrastructure is likely to boost market growth throughout the forecast period. People in underdeveloped nations have limited knowledge of the ease with which disease diagnostics and treatments are available, which is predicted to limit market growth in the coming years. Furthermore, a shortage of trained surgeons is projected to constrain market growth during the forecasted period.

Global Atherectomy Devices Market Regional Analysis

Here is a more detailed regional analysis of the global atherectomy devices market:

North America:

North America leads the global atherectomy devices market due to a high prevalence of cardiovascular diseases, especially peripheral artery disease (PAD). In the United States alone, around 8.5 million people are affected by PAD, with 12-20% of individuals over the age of 60 suffering from the condition, as reported by the CDC. As cardiovascular disease rates continue to rise, with the American Heart Association projecting that 43.9% of the U.S. population will be affected by 2030, the demand for advanced treatment options like atherectomy devices is growing. The region's healthcare systems are well-equipped to handle this demand, and the increasing burden of cardiovascular disease is a key driver behind the market's growth.

North America's strong healthcare infrastructure and rapid adoption of advanced medical technologies are major factors supporting market dominance. The number of endovascular procedures, including atherectomy, has surged by 40% over the past five years, driven by technological advancements and improved patient outcomes. Favorable reimbursement policies are also fueling this growth. Medicare has increased atherectomy reimbursement rates by 15% since 2020, and projections suggest a 7% annual rise in reimbursement for minimally invasive vascular procedures over the next three years.

Asia Pacific:

The Asia Pacific region is experiencing rapid growth in the atherectomy devices market, driven primarily by the rising prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD). According to the World Health Organization (WHO), cardiovascular diseases account for 31% of all deaths in the Western Pacific region, and this figure is expected to rise. The Asia Pacific Society of Cardiology reports a 28% increase in PAD cases over the past decade, with 54 million people affected in 2020, projected to reach 70 million by 2030. The region's aging population further amplifies this trend, as the United Nations predicts that by 2050, one in four people in Asia Pacific will be over the age of 60. This demographic shift is contributing to a growing demand for advanced cardiovascular treatments like atherectomy devices.

The region's improving healthcare infrastructure and increasing healthcare expenditure are key factors driving market growth. Healthcare spending in Asia Pacific has been growing at an average annual rate of 6.5% since 2015, surpassing global averages. This trend is expected to accelerate, with an 8% annual increase projected over the next five years, enabling the adoption of advanced medical technologies such as atherectomy devices.

The rising awareness of minimally invasive procedures has fueled the demand for atherectomy devices. A significant increase in minimally invasive vascular procedures, particularly atherectomy, has been observed across major Asian countries, with a 45% growth between 2018 and 2022. This trend is forecasted to continue, with a projected 60% rise in atherectomy procedures by 2028, further driving the market in the Asia Pacific region.

Global Atherectomy Devices Market: Segmentation Analysis

The Global Atherectomy Devices Market is Segmented on the basis of Type, Application, End User, And Geography.

Atherectomy Devices Market, By Type

Rotational Atherectomy Devices

Directional Atherectomy Devices

Based on Type, the market is fragmented Rotational Atherectomy Devices, Directional, and Atherectomy Devices. Rotational atherectomy devices are currently dominating due to their effectiveness in treating calcified lesions, which are often challenging to manage with other techniques. These devices utilize a rotating diamond-coated burr to remove plaque from arterial walls, making them particularly valuable in complex cases and contributing to their widespread adoption among healthcare providers. Directional atherectomy devices are rapidly growing in popularity, driven by their ability to selectively remove atheromatous material while preserving healthy vascular tissue. As the demand for less invasive and more precise treatment options increases, the directional atherectomy segment is expected to expand significantly, appealing to both physicians and patients seeking optimal outcomes with minimal complications.

Atherectomy Devices Market, By Application

Cardiovascular Applications

Peripheral Vascular Applications

Based on Application, the market is divided into Cardiovascular Applications and peripheral Vascular Applications. Cardiovascular applications dominate due to the high prevalence of coronary artery disease and the need for effective plaque removal techniques in managing complex cardiovascular conditions. These applications are critical as they address the urgent need for advanced treatment options, leading to increased adoption of atherectomy devices in hospitals and surgical centers. Peripheral vascular applications are rapidly growing, driven by the rising incidence of peripheral artery disease (PAD), especially among aging populations. As awareness of PAD and its associated risks increases, there is a greater demand for specialized treatments, including atherectomy procedures, to improve blood flow and alleviate symptoms, positioning this segment for significant growth in the coming years.

Atherectomy Devices Market, By End User

Ambulatory Surgical Centers (ASCs

Hospitals

Based on End User, the market is segmented into Ambulatory Surgical Centers (ASCs) and hospitals. Hospitals dominate as the primary end users due to their advanced surgical capabilities, comprehensive healthcare services, and access to specialized personnel for complex procedures. Hospitals typically handle a larger volume of patients requiring atherectomy procedures, particularly for severe cases of cardiovascular diseases, making them crucial players in this market. Ambulatory Surgical Centers (ASCs) are experiencing rapid growth, driven by the increasing trend toward outpatient procedures and the demand for minimally invasive surgeries. ASCs offer cost-effective and efficient alternatives to traditional hospital settings, attracting patients who prefer quicker recovery times and lower hospital stay durations, thus contributing significantly to the expansion of the atherectomy devices market.

Atherectomy Devices Market, By Geography

North America

Asia Pacific

Europe

Rest of the world

On the basis of geographical analysis, the atherectomy devices market is classified into North America, Asia Pacific, Europe, and Rest of the world. North America dominates the global atherectomy devices market, driven by the high prevalence of cardiovascular diseases like peripheral artery disease (PAD), well-established healthcare infrastructure, and favorable reimbursement policies. The Asia Pacific region is rapidly growing due to the increasing incidence of cardiovascular diseases, an aging population, improving healthcare infrastructure, and rising healthcare expenditures.

Key Players

The "Global Atherectomy Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic, Boston Scientific Corporation, Philips, Cardiovascular Systems Inc., Avinger Inc., Terumo Corporation, B. Braun Melsungen AG, Abbott Laboratories, Ra Medical Systems, and AngioDynamics.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Atherectomy Devices Market Recent developments
• In August 2022, AngioDynamics, Inc. announced that the Auryon Atherectomy System has gained 510(k) clearance for an expanded indication that includes arterial thrombectomy.
• In February 2022, RA Medical Systems announced that enrollment has reached 95 subjects in the pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ATHERECTOMY DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ATHERECTOMY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Directional Atherectomy Systems
• 5.3 Orbital Atherectomy Systems
• 5.4 Photo-Ablative (Laser) Atherectomy Systems
• 5.5 Rotational Atherectomy Systems

6 GLOBAL ATHERECTOMY DEVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Peripheral Vascular
• 6.3 Cardiovascular
• 6.4 Neurovascular

7 GLOBAL ATHERECTOMY DEVICES MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals & Surgical Centers
• 7.3 Research Laboratories & Academic Institutes
• 7.4 Ambulatory Care Centers
• 7.5 Others

8 GLOBAL ATHERECTOMY DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL ATHERECTOMY DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Boston Scientific Corporation
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Abott Laboratories
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Cardiovascular Systems Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 BARD Peripheral Vascular
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Medtronic
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Straub Medical AG
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Cardinal Health
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Volcano Corporation
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research